C2 Pharma

C2 Pharma is a pharmaceutical group established in Luxembourg in 2014. The company produces and sells active pharmaceutical ingredients (APIs) and complex compounds obtained from both natural and synthetic sources.The current API portfolio includes atropine, digoxin, homatropine, pilocarpine, and N-butylbromide scopolamine/hyoscine (SNBB), serving over 100 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, the Middle East, and Africa.They are one of the main sponsors of the "Partnerships for a Better World" program, which ensures the sustainable, traceable, and fair trade collection and sourcing of raw materials for APIs such as pilocarpine. This initiative supports more than 1,000 families and contributes to the preservation of biodiversity in Brazil.